{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:22Z","timestamp":1791994582513,"version":"4.4.0"},"reference-count":7,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["IJDVL"],"DOI":"10.25259\/ijdvl_1291_2024","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:49:16Z","timestamp":1741844956000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combined biological therapy with dupilumab and secukinumab for coexisting bullous pemphigoid and psoriasis"],"prefix":"10.25259","volume":"0","author":[{"given":"Shan","family":"Cao","sequence":"first","affiliation":[{"name":"Department of Dermatology, Hospital for Skin Diseases, Shandong First Medical University, Shandong Province, Jinan, Shandong, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoqi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital for Skin Diseases, Shandong First Medical University, Shandong Province, Jinan, Shandong, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital for Skin Diseases, Shandong First Medical University, Shandong Province, Jinan, Shandong, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital for Skin Diseases, Shandong First Medical University, Shandong Province, Jinan, Shandong, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital for Skin Diseases, Shandong First Medical University, Shandong Province, Jinan, Shandong, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"10.25259\/IJDVL_1291_2024\/ref-1","doi-asserted-by":"publisher","first-page":":953","DOI":"10.1001\/jamadermatol.2023.2428","article-title":"Evaluation of dupilumab in patients with bullous pemphigoid","volume":"159(9)","author":"Zhao","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.25259\/IJDVL_1291_2024\/ref-2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/ajd.12899","article-title":"Association between bullous pemphigoid and psoriasis: systematicSystematic review and meta-analysis of case-control studies","volume":"60","author":"Phan","year":"2019","journal-title":"Australas J Dermatol"},{"key":"10.25259\/IJDVL_1291_2024\/ref-3","doi-asserted-by":"publisher","first-page":":e228","DOI":"10.1111\/jdv.14002","article-title":"A successful treatment with ustekinumab in a case of relapsing bullous pemphigoid associated with psoriasis","volume":"31(5)","author":"Loget","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.25259\/IJDVL_1291_2024\/ref-4","doi-asserted-by":"publisher","first-page":":e155","DOI":"10.1111\/ajd.13803","article-title":"Successful secukinumab treatment of active bullous pemphigoid and chronic severe psoriasis: a case report","volume":"63(2)","author":"Yun","year":"2022","journal-title":"Australas J Dermatol"},{"key":"10.25259\/IJDVL_1291_2024\/ref-5","doi-asserted-by":"publisher","first-page":":e216","DOI":"10.1111\/1346-8138.14760","article-title":"Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid","volume":"46(6)","author":"Kamata","year":"2019","journal-title":"J Dermatol"},{"key":"10.25259\/IJDVL_1291_2024\/ref-6","doi-asserted-by":"publisher","first-page":":956","DOI":"10.1111\/1346-8138.16765","article-title":"Two cases with bullous pemphigoid relapsed after using interleukin-17A inhibitors for psoriasis: A paradoxical reaction","volume":"50(7)","author":"Wang","year":"2023","journal-title":"J Dermatol"},{"key":"10.25259\/IJDVL_1291_2024\/ref-7","doi-asserted-by":"publisher","first-page":":e15754","DOI":"10.1111\/dth.15754","article-title":"Concurrent bullous pemphigoid and plaque psoriasis successfully treated with Janus kinase inhibitor baricitinib","volume":"35(10)","author":"Xiao","year":"2022","journal-title":"Dermatol Ther"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/combined-biological-therapy-with-dupilumab-and-secukinumab-for-coexisting-bullous-pemphigoid-and-psoriasis\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/combined-biological-therapy-with-dupilumab-and-secukinumab-for-coexisting-bullous-pemphigoid-and-psoriasis\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:49:19Z","timestamp":1741844959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/combined-biological-therapy-with-dupilumab-and-secukinumab-for-coexisting-bullous-pemphigoid-and-psoriasis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":7,"alternative-id":["10.25259\/IJDVL_1291_2024"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_1291_2024","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"article-number":"1"}}